Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human Mantle Cell Lymphoma (MCL) cells

Published 2010 View Full Article

Authors

Keywords

Journal

CANCER BIOLOGY & THERAPY

Volume 8, Issue 13, Pages 1273-1280

Publisher

Informa UK Limited

Online

2010-12-29

DOI

10.4161/cbt.8.13.8726

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

CANCER BIOLOGY & THERAPY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Become a Peeref-certified reviewer